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Abstract
Introduction The efficacy of steroid administration before
planned tracheal extubation in critical care patients remains
controversial with respect to the selection of patients most likely
to benefit from this treatment.
Methods We performed an extensive literature search for adult
trials testing steroids versus placebo to prevent reintubation or
laryngeal dyspnoea. Studies were evaluated on a five-point
scale based on randomisation, double-blinding and follow-up.
Our analysis included trials having a score three or higher with
patients mechanically ventilated for at least 24 hours and treated
with steroids before extubation, taking into account the time of
their administration (early vs late) and if the population selected
was at risk or not.
Results Seven prospective, randomised, double-blinded trials,
including 1846 patients, (949 of which received steroids) were
selected. Overall, steroids significantly decreased the risk of
reintubation (relative risk (RR) = 0.58, 95% confidence interval
(CI) = 0.41 to 0.81; number-needed-to-treat (NNT) = 28, 95%
CI = 20 to 61) and stridor (RR = 0.48, 95% CI = 0.26 to 0.87;
NNT = 11, 95% CI = 8 to 42). The effect of steroids on
reintubation and stridor was more pronounced for selected
high-risk patients, as determined by a reduced cuff leak volume
(RR = 0.38, 95% CI = 0.21 to 0.72; NNT = 9, 95% CI = 7 to
19; and RR = 0.40, 95% CI = 0.25 to 0.63; NNT = 5, 95% CI
= 4 to 8, respectively). In contrast, steroid benefit was unclear
when trials did not select patients for their risk of reintubation
(RR = 0.67, 95% CI = 0.45 to 1.00; NNT = 44, 95% CI ≥ 26 to
infinity) or stridor (RR = 0.56, 95% CI = 0.20 to 1.55).
Conclusions The efficacy of steroids to prevent stridor and
reintubation was only observed in a high-risk population, as
identified by the cuff-leak test and when it was administered at
least four hours before extubation. The benefit of steroids
remains unclear when patients at high risk are not selected.
Introduction
Post-extubation stridor associated with post-extubation laryn-
geal oedema is one of the most frequent causes of reintuba-
tion in the intensive care unit (ICU) [1-7]. Reintubation may
result in increased morbidity (for example, nosocomial infec-
tion, prolonged length of ICU stay, additional costs) and mor-
tality [1-4,6,7]. The prevalence of post-extubation stridor
ranges between 6 and 37% of intubated ICU patients [5,8-
13], depending on the studied population (those at high risk or
not). Controversy still exists about the effectiveness of prophy-
lactic steroid therapy to prevent occurrence of both post-extu-
bation stridor and related reintubation in both patients
selected because they are at high risk of stridor and reintuba-
tion [8,9,13] and non-selected patients [10-12,14].
Two recent meta-analyses [15,16], based on original papers
published up to 2007, have been performed. They report con-
tradictory conclusions regarding the efficacy and safety of pro-
phylactic steroid therapy in preventing post-extubation
laryngeal oedema and the need for reintubation in adult ICU
patients. Fan and colleagues [15] have suggested, regarding
the most recent clinical trials, that prophylactic steroid therapy
can reduce the incidence of post-extubation laryngeal oedema
and the subsequent need for reintubation in mechanically ven-
tilated patients. In contrast, Markovitz and colleagues [16]
CI: confidence interval; ICU: intensive care unit; NNT: number needed to treat; RCT: randomised controlled trial; RR: relative risk.Critical Care    Vol 13 No 2    Jaber et al.
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concluded that using steroids to prevent (or treat) stridor after
extubation has not proven effective for neonates, children or
adults. By reporting conflicting results, recent trials [8,9,13]
and the two meta-analyses [15,16] have intensified the debate
surrounding the use of prophylactic steroid therapy to prevent
both post-extubation stridor occurrence and reintubation.
Moreover, the meta-analyses results were pooled from trials
which included selection of patients at risk of post-extubation
stridor development [8,9,13] and unselected patients with an
no risk of post-extubation stridor development [10-12,14] and
allowed for very different steroid administration regimens (well
in advance of extubation or immediately before). Indeed, the
anti-inflammatory effect of steroids, the main mechanism
responsible for reduction of post-extubation laryngeal
oedema, is time-course dependant [17,18]. Although the two
meta-analyses [15,16] allowed for these differences, they did
not perform subgroup analyses of the early versus late steroid
administration nor for selected high-risk patients versus unse-
lected patients. Finally in 2007, two additional randomised
clinical trials (RCTs) were presented in abstract form but were
not included in these two meta-analyses [8,14]. Thus, we per-
formed a quantitative meta-analysis to evaluate the effective-
ness of prophylactic steroid therapy to prevent reintubation
and post-extubation stridor, taking into account the studied
populations (at risk to develop post-extubation stridor or not)
and the steroid administration regimen (pre-extubation early
versus late).
Materials and methods
QUOROM standards were followed during all phases of the
design and implementation of this meta-analysis [19].
Identification of the studies
Three electronic databases were searched via the Internet for
studies published between January 1966 and November
2008: PubMed® (MEDLINE/Index Medicus), the Cochrane
Controlled Trials Register published by the Cochrane Library
and EMBASE. The Medical Subject Heading terms used for
the search were steroids and extubation, adults and rand-
omized controlled trials. Supplementary manuscripts were
searched by changing the Medical Subject Heading term ster-
oids to dexamethasone, prednisolone, methylprednisolone or
hydrocortisone. Additional references were retrieved by click-
ing on the 'related articles' hyperlinks in Medline and by man-
ually searching reference lists in original published articles,
review articles and correspondence. To complete the search
with the inclusion of non-published trials, abstracts presented
at different critical care meetings (American Thoracic Society,
Society of Critical Care Medicine, American Society of
Anesthesiology, European Society of Anaesthesiology, Euro-
pean Society of Intensive Care Medicine, International Sympo-
sium on Intensive Care and Emergency Medicine, Societé
Française d'Anesthésie-Réanimation and Société de Réani-
mation en Langue Française) were also screened. For
abstracts, only the past three years were consulted. For some
trials, the authors were contacted for additional information on
the results [8,14].
Quality assessment of the studies
Each study was subjected to quality assessment by two inves-
tigators (SJ and BJ) who were not blinded to the authors or
results. Disagreements between the two investigators were
resolved by discussion. In the case of persistent disagree-
ment, a third reviewer (EM) helped to reach a consensus after
separately reviewing the report. Each article was scored using
a five-point scale that evaluates randomisation, blinding and
completeness of patient follow-up (Jadad scale) [20]. One
point was given if the study was described as randomised. An
additional point was given if the randomisation method was
described and was appropriate (for example, computer-gener-
ated table of random numbers), whereas a point was sub-
tracted if the randomisation method was described and
inappropriate (for example, alternate allocation or allocation by
date of birth). Similarly, one point was assigned to studies
described as double-blinded, two points were assigned to
studies for which the double-blinding method was described
and appropriate (for example, identical placebo, active pla-
cebo, double-dummy) and zero points were assigned to stud-
ies for which the double-blinding method was described and
inappropriate. One point was given if the article specified the
numbers of and reasons for withdrawals and dropouts. Thus,
the minimum score for a randomised study was one and the
highest possible score was five. We included studies with a
score of three or greater [20].
Selection criteria
Criteria for study selection were as follows: randomised, dou-
ble-blind design; quality assessment score of three or greater
[20]; duration of mechanical ventilation longer than 24 hours;
steroids administrated before a planned extubation.
Criteria for study exclusion were a score of two or less on the
three-item Jadad quality five-point scale; duration of mechani-
cal ventilation less than 24 hours (for example, mechanical
ventilation for anaesthesia); trials that studied steroid adminis-
tration for the prevention of pulmonary fibrosis (for example,
excessive fibroproliferation or bronchopulmonary dysplasia);
paediatric or neonatal patients.
Outcome measures
The primary evaluation criterion was the incidence of reintuba-
tion. The other endpoints of post-extubation stridor, duration of
ICU stay and mortality were analysed. When trials compared
more than two groups, data were extracted into two groups:
steroid and control. In dose-ranging studies with a placebo
group, we extracted the events of the control group and
pooled the steroid groups. When authors compared two types
of administration with the same dose of steroids (single injec-
tion vs. intermittent or bolus group), patients receiving steroids
were pooled and compared with those receiving placebo.Available online http://ccforum.com/content/13/2/R49
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Sensitivity analysis was performed to explore the effect of ster-
oid in different populations, namely in trials which selected
patients at high risk for reintubation or not. Similarly, subgroup
analysis for time of administration was conducted in groups of
patients who received steroids 'late' (less than two hours
before extubation) or 'early' (more than four hours before extu-
bation).
Statistics
Data were extracted as they were reported in the original
paper or based on the answers of the authors to our queries.
The Mantel-Haenszel-like procedure for relative risk (RR) was
used to pool RRs [21]. Analyses were performed with Rev
Man review manager (version 4.2, Cochrane Collaboration,
The Nordic Cochrane Centre, Copenhagen). The RRs (and
95% confidence intervals (CI)) were calculated, and the
results were expressed graphically. All criteria were analysed
separately. A random-effects analysis was conducted if the
result of a Q Cochrane heterogeneity test was significant (P <
0.1) and heterogeneity was quantified by I2 [22]. For the signif-
icant criteria, we computed the number needed to treat (NNT)
as the inverse of the difference of the proportion of patients
who had any event in the steroid groups and the control
groups. CIs of the NNT were constructed by inverting and
exchanging the limits of the 95% CI for the RR. The NNT and
95% CI were calculated with the Internet-based program Vis-
ual Rx [23]. All tests were two sided, and P values less than
0.05 were considered statistically significant.
A funnel plot (plot of treatment effect against trial precision)
was also created to determine the presence of publication
bias and other possible biases (English language, citation and
multiple publication), true heterogeneity, data irregularities and
choice of effect measure in the meta-analysis [24]. In the pres-
ence of bias that usually leads to an overestimate of the treat-
ment effect, the funnel plot is skewed and asymmetrical. The
degree of asymmetry was measured by the Egger test [25]
using WeasyMA software (ClinInfo, Lyon, France) [26]. A P
value less than 0.1 was considered statistically significant for
asymmetry.
Results
Identification of the trials
Fifty-six relevant RCTs were identified by Medline, the
Cochrane Library, Embase and hand-searching. Forty-eight
were excluded for the following reasons: 29 were surgical
patients (evaluation of steroid neuromuscular block or steroids
to prevent postoperative nausea or vomiting); 10 studies
investigated the endocrine stress response; six trials evalu-
ated the effect of steroids on ventilation weaning after cardiac
surgery; two trials investigated long-term administration of
steroids in patients with acute respiratory distress syndrome;
and one trial studied the effect of steroids on healing after tho-
racic surgery (Figure 1). One RCT was excluded because the
quality assessment score was less than three [26]. Two trials
were found after consulting conference abstracts [8,14].
Seven studies were finally selected including 1846 adult
patients. Nine hundred and forty-nine patients were included
in the steroid group, versus 897 in the placebo group (Figure
1).
Study designs and patients
The characteristics of the seven RCTs are summarised in
Table 1. All seven randomised double-blinded studies were
published in or after 1992. Two trials [8,14] were presented at
the American Thoracic Society conference in 2007 and one
author answered our queries concerning additional data [8].
The median quality score of data reporting was five (range =
three to five). All studies were double-blinded; the procedure
of randomisation was adequately described in five out of seven
studies. Type of corticosteroid, doses, timing and duration of
administration varied from one trial to another (Table 1). Three
trials only included patients at high risk of distress after
planned extubation based on a reduced cuff-leak volume
[8,9,13]. One trial [9] had three arms; it compared patients
that received a placebo with patients that received one injec-
tion of methylprednisolone (low-dose steroid arm) and
patients that received four injections of corticosteroid (high-
dose steroid arm); these two steroid arms were thus combined
for the analyses.
Post-extubation stridor was mainly defined by the occurrence
of stridor after extubation, except in two trials where the
authors included patients with stridor and laryngeal obstruc-
tion dyspnoea defined by the occurrence of signs of upper air-
Figure 1
Flowchart of randomised controlled trials selected for the meta-analysis Flowchart of randomised controlled trials selected for the meta-analy-
sis. ARDS = acute respiratory distress syndrome.Critical Care    Vol 13 No 2    Jaber et al.
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way obstruction, that is, a prolonged inspiratory phase
associated with recruitment of accessory respiratory muscles
[10,12]. Post-extubation laryngeal oedema was confirmed by
examination using bronchoscopy or laryngoscopy in two trials
[9,11].
Outcomes
Outcomes according to populations included in the trials: 
overall, unselected and selected patients at high risk of 
developing post-extubation stridor and reintubation as 
defined by a reduced cuff-leak volume
The rates of reintubation were obtained for all selected trials.
Figure 2 demonstrates a significant difference in the reintuba-
tion rate after a planned extubation, with 8.7% (range = 2.6%
to 30.3%) in the controls and 5.4% (range = 0% to 12.9%) in
the steroid-treated patients (RR = 0.58, 95% CI = 0.41 to
0.81, P = 0.001). This indicates a 42% decrease in the risk of
reintubation. The NNT overall patients (unselected and
selected patients) was 28 (95% CI = 20 to 61; Table 2). Sub-
group analysis was performed by pooling trials that selected
high-risk patients by measuring the leak around the deflated
endotracheal tube cuff. The risk of reintubation was more
greatly reduced by steroids when only trials with these high-
risk patients were considered. The rate of reintubation
decreased from 19.8% to 8.6% (RR = 0.38, 95% CI = 0.21
to 0.72, P = 0.003) The NNT of high-risk patients was 9 (95%
CI = 7 to 19; Figure 2 and Table 2). In comparison, the risk
reduction appears less well defined when trials did not select
patients for risk of reintubation (RR = 0.67, 95% CI = 0.45 to
1.00, P = 0.05; NNT = 44, 95% CI ≥ 26 to infinity; Table 2).
Stridor was described in the seven RCTs (Figure 3). Among
the 897 patients who did not receive steroid therapy before
extubation, 167 experienced symptomatic post-extubation stri-
Table 1
Characteristics of the seven adult studies included in the meta-analysis
Author, year Jadad
scale
Overall
sample
size analysed
(n)
ICU population
and inclusion 
criteria
Duration of 
ventilation
(days)
(steroid vs placebo)
Steroid dose and
regimen 
administration
Overall
equivalent dose of
hydrocortisone (mg)
Cheng and 
colleagues 2007 [8]
3 71 Medical and surgical
MV for more than 24 
hours
High risk of stridor 
(CLV < 24%)
NR Methylprednisolone IV 
40 mg, 4 hours before 
extubation
200
Cheng and 
colleagues 2006 [9]
5 128 Medical and surgical
MV for more than 24 
hours
High risk of stridor 
(CLV < 24%)
7.3 ± 3.9 (1 inj)
6.3 ± 3.8 (4 inj)
vs 7.1 ± 4.1 
(placebo)
Methylprednisolone IV 
40 mg/6 hours × 4 vs 
Methylprednisolone IV 
40 mg – 1 injection vs 
placebo
Started 24 hours 
before extubation
800 or 200
Darmon and 
colleagues 1992 
[10]
5 694 Medical and surgical
MV for more than 36 
hours
Not selected at high-
risk
9.6 ± 9.7
vs 10.3 ± 10.9
Dexamethasone IV 8 
mg one hour before 
extubation
213
Francois and 
colleagues 2007 
[11]
5 698 Medical, surgical and 
trauma
MV for more than 36 
hours
Not selected at high-
risk
Duration of MV < 7 
days: 51 vs 49%
Duration of MV > 7 
days: 49 vs 51%
Methylprednisolone IV 
20 mg/4 hours 
starting 12 hours 
before planned 
extubation 
(last dose just before 
extubation)
400
Ho and colleagues 
1996 [12]
5 77 Medical and surgical
Not selected at high-
risk
6.1 ± 3.8
vs 4.6 ± 4.7
Hydrocortisone IV 
100 mg one hour 
before extubation
100
Lee and colleagues 
2007 [13]
58 6 M e d i c a l
MV for more than 48 
hours
High risk of stridor 
(CLV < 110 ml)
7.0 ± 2.0
vs 6.6 ± 2.0
Dexamethasone IV 5 
mg/6 hours × 4 – 
started 24 hours 
before extubation, last 
dose just before 
extubation
533
Shih and colleagues 
2007 [14]
3 98 Medical and surgical
MV for more than 24 
hours
Between 10 and 15 Hydrocortisone IV 4 
injections/6 hours
Started 24 hours 
before
NR
CLV = cuff-leak volume; ICU = intensive care unit; IV = intra-venous; MV = mechanical ventilation; NR = not reported.Available online http://ccforum.com/content/13/2/R49
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dor (18.6%; range = 9.1% to 48.5%; Figure 3). In one trial
[13], 9 of 11 patients had severe respiratory distress that
required non-invasive positive pressure ventilation. Of the 949
patients who received corticosteroids, 77 (8.1%; range =
2.8% to 23.7%) experienced symptomatic laryngeal obstruc-
tion (RR = 0.48, 95% CI = 0.26 to 0.87, P = 0.02; Figure 3).
Eleven patients needed to be treated to prevent one patient
from developing stridor (95% CI = 8 to 42) in the overall pop-
ulation (selected and unselected patients; Table 2). Aerosol
with adrenaline (n = 19) and non-invasive positive pressure
ventilation (n = 3) were used to treat laryngeal dyspnoea in the
steroid group [9,12,13].
Similar to reintubation, subgroup analysis was performed to
evaluate patients at a higher risk for laryngeal dyspnoea. In
high-risk patients, based on reduced cuff-leak volume, the
overall incidence was 34.5% for the control groups and
12.9% in the steroid groups. In this context, the relative benefit
was 0.40 (95% CI = 0.25 to 0.63, P < 0.001; NNT = 5, 95%
CI = 4 to 8; Table 2). In contrast, steroids did not significantly
reduce the incidence of post-extubation stridor when high-risk
patients were not selected (RR = 0.56, 95% CI = 0.20 to
1.55; Figure 3). Moreover, the coefficient of heterogeneity (I2)
was high, presumably explained by the trial performed by Fran-
cois and colleagues [11]. After exclusion of this study, the
coefficient of heterogeneity was 0 (RR = 0.89, 95% CI = 0.61
to 1.30). A funnel plot of the treatment effect (logarithm RR of
Table 2
Number needed to treat with steroids to reduce reintubation and stridor in unselected, selected and overall populations
Unselected Selected Overall
(unselected+selected)
NNT to prevent one reintubation episode 44 (95% CI ≥ 26 to ∞) 9 (95% CI = 7 to 19) 28 (95% CI = 20 to 61)
NNT to prevent one stridor episode Not calculated 5 (95% CI = 4 to 8) 11 (95% CI = 8 to 42)
Selected population is defined as patients at high risk of developing post-extubation stridor and reintubation in which the cuff-leak test showed 
absence or a low level of leak (less than 110 to 140 ml in absolute value or less than 12% to 25% in relative value).
Unselected population is defined as patients included in trials that did not use the cuff-leak test to select patients.
Overall population is defined as patients included in both trials that did use and did not use the cuff-leak test to selected patients 
(unselected+selected).
The NNT was calculated only when a significant result was observed.
CI = confidence interval; NNT = number needed to treat.
Figure 2
Risk of reintubation according to the studied population Risk of reintubation according to the studied population. Risk ratio of reintubation rate for the individual randomised controlled trials comparing ster-
oids with control groups. Vertical line = 'no difference' point between the two groups; squares = risk ratios (the size of each square denotes the pro-
portion of information given by each trial); diamonds = pooled risk ratios for randomised controlled trials that did not select patients at high risk 
(upper) and trials that did select patients at high risk, based on a reduced cuff-leak volume (CLV; lower); horizontal lines = 95% confidence intervals 
(CI).Critical Care    Vol 13 No 2    Jaber et al.
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reintubation) versus trial precision was symmetric and centred
around an RR of less than 1.0, suggesting that there is no pub-
lication bias or other biases (Figure 4).
No additional information with respect to outcomes of patients
(death, duration of ventilation, infection and cost) that required
reintubation was provided by the authors in the articles. Fran-
cois and colleagues [11] reported one death in each group;
the reason was respiratory failure and septic shock in the pla-
cebo and corticosteroid groups, respectively. Five trials found
that women have a significantly higher risk of symptomatic
laryngeal oedema after extubation [9-12,14].
Outcomes according to when steroid administration was 
initiated before extubation: 'late' defined by starting less 
than two hours before planned extubation versus 'early' 
administration defined by starting steroid administration at 
least four hours (range = 4 to 24 hours) before planned 
extubation
In the subgroup of patients with a high risk for post-extubation
stridor, steroids were always administrated early (more than
four hours before the planned extubation; Figure 2). In con-
trast, timing of initiation of steroid administration varied from
one trial to another when authors did not select patients at
high risk. Among the four studies that included patients not
selected as being at high risk [10-12,14], two trials used a
Figure 3
Risk ratio for post-extubation stridor according to the studied population Risk ratio for post-extubation stridor according to the studied population. Risk ratios of post-extubation stridor rate for the individual randomised con-
trolled trials comparing steroids with control groups and the pooled analysis. Vertical line = 'no difference' point between the two groups; squares = 
risk ratios (the size of each square denotes the proportion of information given by each trial); diamonds = pooled odds ratios for randomised control-
led trials that did not select patients at high risk (upper) and trials that did selected patients at high risk, based on a reduced cuff leak volume (CLV; 
lower); horizontal lines = 95% confidence intervals (CI).
Figure 4
Funnel plot for outcome reintubation to detect bias or systematic heter- ogeneity in trials according to the studied population (selected vs unse- lected patients at risk based on a reduced cuff-leak volume) Funnel plot for outcome reintubation to detect bias or systematic heter-
ogeneity in trials according to the studied population (selected vs unse-
lected patients at risk based on a reduced cuff-leak volume). Each point 
represents one trial. SE = Standard Error. RR = Relative Risk.Available online http://ccforum.com/content/13/2/R49
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protocol with an early injection, namely more than four hours
before extubation [11,14], and the two others injected ster-
oids just before the extubation [10,12]. Pooled together, these
two trials [10,12] did not show that steroids decrease the risk
of reintubation (RR = 0.88, 95% CI = 0.48 to 1.61; Figure 5)
or stridor (RR = 0.81, 95% CI= 0.53 to 1.25; Figure 6). How-
ever, an anticipated administration of steroids (more than four
hours before planned extubation) significantly decreases the
risk of reintubation (RR = 0.55, 95% CI = 0.32 to 0.94; NNT
= 26, 95% CI= 17 to 193; Figure 5) but not for stridor (RR =
0.41, 95% CI = 0.05 to 3.59; Figure 6).
Discussion
The present meta-analysis documents that steroid administra-
tion before a planned extubation decreases the risk of post-
extubation stridor and reintubation both in high-risk and unse-
lected patients. The beneficial effect of steroids to prevent
post-extubation stridor and reintubation was clear in the sub-
group of patients at high-risk for development of post-extuba-
tion stridor as identified by a cuff-leak test (a low level of leak
less than 110 ml or less than 25%).
The discrepancies observed in studies that evaluated the inter-
est to administer steroids before extubation could be due to
several factors including patient inclusion criteria, duration of
intubation, dosage, timing of treatment and risk levels of devel-
oping stridor. Only the last two criteria (risk levels of develop-
ing stridor and timing of administration initiation) could be
extensively evaluated in the present meta-analysis, allowing
their importance to be reported for the first time. Post-extuba-
tion stridor is commonly the result of oedema of the subglottic
area or the vocal cords. The difficulty in defining the relation-
ship between laryngo-tracheal injury and post-extubation stri-
dor is that the presence of the endotracheal tube precludes
direct visualisation of the upper airway before extubation.
The ability to predict which patients will develop stridor follow-
ing extubation, possibly culminating in reintubation, is obvi-
ously a desirable goal. Beyond assessment of risk factors,
clinicians have long used the cuff-leak test to predict post-
extubation airway patency, wherein the endotracheal tube cuff
is deflated and a leak of air around the tube is sought during
either spontaneous ventilation (with the endotracheal tube
lumen occluded) or positive-pressure ventilation. The cuff-leak
test may be performed using the 'qualitative method' (pres-
ence or absence of air leak around the tube when the cuff is
deflated) or the 'quantitative method' by reporting the leak vol-
ume (inspired minus exhaled tidal volume during positive-pres-
sure ventilation when the cuff is deflated) or the fraction of leak
volume (inspired minus exhaled volume divided by inspired
tidal volume when the cuff is deflated). Several cuff-leak test
studies [5,9,27-30] suggest that the presence of an air leak is
associated with a low likelihood of clinically important post-
extubation stridor, whereas the absence or a low level of leak
Figure 5
Risk for reintubation according to the steroid administration initiation timing before extubation in unselected patients Risk for reintubation according to the steroid administration initiation timing before extubation in unselected patients. Risk ratios of reintubation rate 
for the individual randomised controlled trials comparing steroids with control groups and the pooled analysis. Vertical line = 'no difference' point 
between the two groups; squares = odds ratios (the size of each square denotes the proportion of information given by each trial); diamonds = 
pooled odds ratios for randomised controlled trials with for which steroid administration was started less than two hours before planned extubation 
(upper) and trials for which steroid administration was started at least four hours (ranged 4 to 24 hours) before planned extubation (lower); horizontal 
lines = 95% confidence intervals (CI). CLV = cuff-leak volume.Critical Care    Vol 13 No 2    Jaber et al.
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(less than 110 to 140 ml in absolute value or less than 12% to
25% in relative value) is associated with a high incidence of
stridor and reintubation. The use of the cuff-leak test should be
standardised and take into account a possible discrepancy
between inspired and exhaled tidal volume measurement
devices together with significant breath by breath variability.
A more reliable identification of patients at high-risk of devel-
oping post-extubation stridor and reintubation would appear
desirable not only to decrease the risk of reintubation, but also
to avoid excessive steroid treatment as it may induce adverse
effects in patients for whom there is no need. Indeed as shown
in the present meta-analysis, the NNT to prevent one stridor
episode decreased from 11 in the overall population (selected
and unselected) to five in a population determined to be at
high-risk of developing post-extubation stridor as determined
by the cuff-leak test (Figure 3 and Table 2). However, steroids
did not significantly reduce the incidence of post-extubation
stridor when patients were not selected (that is, unselected
patients) for their risk of post-extubation stridor. The NNT to
avoid one reintubation decreased from 28 in the overall popu-
lation (selected and unselected) to nine in patients at high risk
(Figure 2 and Table 2). On the other hand, the benefit of ster-
oids is unclear when trials did not use the cuff-leak test to
selected patients. In this case, the NNT increased to 44 and
the upper limit of the CI is infinity (Figure 2 and Table 2).
Although steroids are potentially associated with several
adverse effects (such as hyperglycaemia, arterial hyperten-
sion, agitation and infection) when they are administered for a
few days (more than 48 hours) [31], side effects associated
with steroid treatment for less than 24 hours are minimal
[17,18]. The studies included in the present meta-analysis
reported no side effects related to steroids, but detection of
steroid-related adverse events was not specifically studied in
these trials.
Laryngotracheal injury related to intubation may cause narrow-
ing of the airway mainly due to inflammatory oedema. The
potential capacity of steroids to relieve laryngeal oedema is
mainly due to its anti-inflammatory effects, which inhibit the
release of inflammatory mediators and decrease capillary per-
meability [9,11,13,18]. The initial anti-inflammatory effects
start at least one to two hours after intravenous administration
and maximal effects appear between 2 and 24 hours, depend-
ing on steroid type and administered dose [9,11,17,18].
Indeed, a single injection of dexamethasone (1 mg/kg) one
hour before extubation had no effect on subglottic histological
injury in a rabbit model [32,33]. Moreover, in the two trials
[10,12] included in the present meta-analysis in which ster-
oids were administered one hour before extubation, no signif-
icant difference was observed between control and steroid
groups for post-extubation stridor and reintubation rates. The
same is true for the study by Gaussorgues and colleagues
Figure 6
Risk for post-extubation stridor according to the timing steroid administration initiation before extubation in unselected patients Risk for post-extubation stridor according to the timing steroid administration initiation before extubation in unselected patients. Risk ratios of post-
extubation stridor rate for the individual randomised controlled trials comparing steroids with control groups and the pooled analysis. Vertical line = 
'no difference' point between the two groups; squares = odds ratios (the size of each square denotes the proportion of information given by each 
trial); diamonds = pooled odds ratios for randomized controlled trials for which steroid administration was started less than two hours before 
planned extubation (upper) and trials for which steroid administration was started at least four hours (ranged 4 to 24 hours) before planned extuba-
tion (lower); horizontal lines = 95% confidence intervals (CI). CLV = cuff-leak volume.Available online http://ccforum.com/content/13/2/R49
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[25] for which steroids were also administered one hour
before extubation and no significant difference was observed
between control and steroid groups for post-extubation stridor
and reintubation rates. Although the study by Gaussorgues
and colleagues [25] was excluded because the quality
assessment score was less than three, the inclusion of this
study [25] would not change the conclusions of the present
meta-analysis. Except for one trial presented in abstract form
at a congress [14], all the published RCTs in which steroids
were administered at least 4 to 24 hours before extubation
(Table 1 and Figures 5 and 6) reported a significant decrease
in post-extubation stridor [8,9,11,13] and reintubation
[8,9,11].
It might be argued that the use of corticosteroids in adult crit-
ical care for planned extubation is unnecessary, because
objectively the incidence of reintubation is low and sympto-
matic laryngeal oedema has self-limited symptoms. However,
stridor and laryngeal dyspnoea increase care needs because
of the administration of adrenaline or corticosteroid aerosol
and associated nursing time. Similarly, reintubation increases
cost, morbidity, care needs, and both ICU and hospital lengths
of stay. Unfortunately, trials included in the current meta-anal-
ysis evaluated the benefit of corticosteroids only during the
first 48 hours and no information on the outcome of reintu-
bated patients was provided. Further studies on this topic are
needed; using standard criteria for the assessment of readi-
ness to extubate and a well-defined evaluation on the relation
between post-extubation laryngeal oedema and re-intubation.
The quality of the trials included in a systematic review may
alter the results [34], because meta-analyses are often handi-
capped by the heterogeneity of the included trials. Moher and
colleagues [34] demonstrated that meta-analyses with low-
quality trials (Jadad assessment scale of two or less) com-
pared with high-quality trials (Jadad assessment scale above
two) were associated with a 33% increase in the estimated
benefit. Similarly, trials using inadequate allocation conceal-
ment may also overestimate the benefit of treatment by as
much as 37% [34]. Therefore, multiple scales have been pro-
posed to assess the quality of trials included in a meta-analysis
in order to decrease bias due to the inclusion of low-quality tri-
als. We used the Jadad composite scale [20] to assess qual-
ity, using the following items: randomisation, double-blinding
and patient withdrawals.
Meta-analyses of trials with low quality, as evaluated with this
scale, significantly exaggerate benefits [19,34]. All seven trials
selected for our systematic review have a scale reflecting high
quality [34] and, consequently, were double-blinded and ran-
domised. Patients included in trials have variable risks for post-
extubation stridor or reintubation. Interestingly, the reduction
of risk for stridor appears to be similar (approximately 50%),
regardless of the risk of post-extubation laryngeal dyspnoea,
suggesting that the effect is the same in the presence of
oedema. Dosage, duration and type of corticosteroids differed
from one trial to another. Pooling RCTs with varying designs
may be interesting because the current meta-analysis appears
to demonstrate that the timing of the first administration influ-
ences the risk of reintubation.
The current meta-analysis suggests an effect of administration
timing on the efficacy of corticosteroids, because steroids
appear to prevent reintubation more effectively if they are
administrated at least four hours before planned extubation.
As stridor and reintubation, secondary to upper obstruction
airway obstruction, occur soon after extubation [5,11], it may
be reasonable to suggest starting steroid treatment at least
four hours before planned extubation to prevent prolongation
of weaning from mechanical ventilation.
Further studies should be conducted to better define the opti-
mal use of steroids to prevent extubation failure. In patients
selected at high risk for postextubation stridor (for example,
traumatic intubation, low cuff-leak value or previous extubation
failure) steroids should be used but the optimal steroid to use
before extubation without delay remains to be established, as
does steroid type, dosing regimen, administration timing and
duration. Dose response should also be established to
achieve the lowest effective dose. Moreover, the risk of steroid
use remains a source of concern in critical care patients. The
side effects of steroid administration to prevent reintubation
are unknown and were not investigated clearly in all trials
included in this meta-analysis. The current meta-analysis
showed no benefit when trials that did not select patients at
risk for reintubation were pooled. In this group, only one trial
[5,11] found a significant benefit of steroid use but the others
found no benefit. The study by Francois and colleagues [11]
appears to be the main cause of heterogeneity between the tri-
als that did not select patients at risk. The timing of administra-
tion does not seem to be the major reason for heterogeneity
because the study by Shih and colleagues [14] administrated
steroid sooner than Francois and colleagues [11] (24 hours
compared with 12 hours, respectively). Another hypothesis
may be the dose of steroid used by Francois and colleagues
[11] because they administrated the highest dose among all
trials studied. Finally, all trials have the possibility of giving a
significant result even if one is not available (Type I error).
Thus, the evidence for steroid administrated in unselected
patients remains unclear and additional studies are warranted
to clearly determine the benefits, but also the potential adverse
effects, of this group of drugs.
Conclusions
The present meta-analysis suggests a beneficial effect of ster-
oids to prevent post-extubation stridor and reintubation was
observed in the subgroup of patients with a high risk of devel-
oping post-extubation stridor, as identified by the cuff-leak
test, and that steroid treatment before a planned extubation
decreases the risk of reintubation only if intravenous steroidCritical Care    Vol 13 No 2    Jaber et al.
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administration was performed at least four hours before
planned extubation. The benefit of steroids remains unclear
when high-risk patients are not selected.
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